Plain-English translation of NCT04533217 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a procedure called vertebroplasty can help reduce pain in patients with multiple myeloma who have developed fractures in their spine bones. Vertebroplasty is a minimally invasive procedure where a special cement-like material is injected into fractured vertebrae to stabilize them and ease pain. Half the patients will receive vertebroplasty plus their regular myeloma medications, while the other half will receive standard care alone.
Patients with multiple myeloma often develop painful fractures in their spine bones, which can severely impact quality of life and mobility. This trial exists to determine whether adding a spine-strengthening procedure to regular myeloma treatment can provide better pain relief and improve outcomes for these patients.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will first complete pain and quality-of-life questionnaires with your doctor. You will then be randomly assigned to either receive vertebroplasty (a same-day minimally invasive procedure) plus your regular myeloma medications, or to continue with standard medical care alone. You will be followed over time to track your pain levels and how well you're doing, with check-ins and additional questionnaires to measure changes in your symptoms and everyday function.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Denmark